AU3204895A - Methods of selecting a random peptide that binds to a target protein - Google Patents

Methods of selecting a random peptide that binds to a target protein

Info

Publication number
AU3204895A
AU3204895A AU32048/95A AU3204895A AU3204895A AU 3204895 A AU3204895 A AU 3204895A AU 32048/95 A AU32048/95 A AU 32048/95A AU 3204895 A AU3204895 A AU 3204895A AU 3204895 A AU3204895 A AU 3204895A
Authority
AU
Australia
Prior art keywords
binds
selecting
methods
target protein
random peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU32048/95A
Inventor
Christian C Fritz
Michael R Green
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Massachusetts Medical Center
Original Assignee
University of Massachusetts Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Massachusetts Medical Center filed Critical University of Massachusetts Medical Center
Publication of AU3204895A publication Critical patent/AU3204895A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1055—Protein x Protein interaction, e.g. two hybrid selection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
AU32048/95A 1995-02-01 1995-07-27 Methods of selecting a random peptide that binds to a target protein Abandoned AU3204895A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38180095A 1995-02-01 1995-02-01
US381800 1995-02-01
PCT/US1995/009589 WO1996023899A1 (en) 1995-02-01 1995-07-27 Methods of selecting a random peptide that binds to a target protein

Publications (1)

Publication Number Publication Date
AU3204895A true AU3204895A (en) 1996-08-21

Family

ID=23506412

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32048/95A Abandoned AU3204895A (en) 1995-02-01 1995-07-27 Methods of selecting a random peptide that binds to a target protein

Country Status (2)

Country Link
AU (1) AU3204895A (en)
WO (1) WO1996023899A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6365344B1 (en) 1996-01-23 2002-04-02 The Board Of Trustees Of The Leland Stanford Junior University Methods for screening for transdominant effector peptides and RNA molecules
WO1997027213A1 (en) * 1996-01-23 1997-07-31 The Board Of Trustees Of The Leland Stanford Junior University Methods for screening for transdominant effector peptides and rna molecules
GB9701425D0 (en) * 1997-01-24 1997-03-12 Bioinvent Int Ab A method for in vitro molecular evolution of protein function
DE19805334A1 (en) * 1998-02-11 1999-08-12 Otogene Biotechnologische Fors Process for the development of an active pharmaceutical ingredient
EP0972780A1 (en) * 1998-05-18 2000-01-19 Applied Research Systems ARS Holding N.V. Il-6 antagonist peptides
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
SI2319928T1 (en) 1998-10-23 2013-08-30 Kirin-Amgen, Inc. Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity
CA2407956A1 (en) * 2000-05-03 2001-11-08 Amgen Inc. Modified peptides as therapeutic agents
FR2860237B1 (en) * 2003-09-30 2006-03-10 Centre Nat Rech Scient INTERACTION POLYPEPTIDE COMPRISING A HEPTAPEPTIDE PATTERN AND A CELL PENETRATION DOMAIN
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
EP3897652A4 (en) 2018-12-20 2022-09-14 KSQ Therapeutics, Inc. Substituted pyrazolopyrimidines and substituted purines and their use as ubiquitin-specific-processing protease 1 (usp1) inhibitors
US11718624B2 (en) 2020-10-30 2023-08-08 KSQ Therapeutics, Inc. Solid state forms of substituted pyrazolopyrimidines and uses thereof
WO2023066881A1 (en) 2021-10-18 2023-04-27 Astrazeneca Ab Inhibition of map3k15 for treating and preventing diabetes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283173A (en) * 1990-01-24 1994-02-01 The Research Foundation Of State University Of New York System to detect protein-protein interactions
US5723286A (en) * 1990-06-20 1998-03-03 Affymax Technologies N.V. Peptide library and screening systems

Also Published As

Publication number Publication date
WO1996023899A1 (en) 1996-08-08

Similar Documents

Publication Publication Date Title
AU6311996A (en) Peptide inhibitors of fibronectine
AU5956196A (en) Methods of increasing accumulation of essential amino acids n seeds
AU7566396A (en) Process for the preparation of peptides by way of streptavidin fusion proteins
AU5324996A (en) Protein kinase c inhibitors
AU7203496A (en) Novel peptides
AU7516694A (en) Biotinylation of proteins
AU3204895A (en) Methods of selecting a random peptide that binds to a target protein
AU7631496A (en) Substituted 2-anilinopyrimidines useful as protein kinase inhibitors
AU5893696A (en) Modification of polypeptides
AU6046696A (en) Peptides and compounds that bind to a receptor
AU7317496A (en) Activation of p53 protein
AU5289596A (en) Peptide suppressing ixbalpha phosphorylation
AU5893796A (en) Modification of polypeptides
AU4427296A (en) Novel peptide
AU7294396A (en) Protein detection
AU4394396A (en) Modified peptides
AU4953796A (en) Dipeptide compounds having ahpba structure
AU6873596A (en) Allergen-xcd32 fusion proteins
AU5532796A (en) Pharmaceutical preparations derived from korean mistletoe
EP0831878A4 (en) Novel peptide inhibitors of calmodulin
AU5550296A (en) Conotoxin peptides
AU5440596A (en) Inhibiting degradation of a degron-bearing protein
AU7520396A (en) Abl-interactor protein
AU2365795A (en) Multiple administrations of anti-tnf antibody
AU5284296A (en) Immune-evading proteins